| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2576129 | The American Journal of Geriatric Pharmacotherapy | 2006 | 11 Pages |
Abstract
In these pooled analyses, solifenacin 5 and 10 mg once daily were efficacious and well tolerated in the treatment of these elderly subjects with OAB. Solifenacin therapy was also associated with a high level of persistence in a 40-week extension trial.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
MD Wagg, MD Wyndaele, MD Sieber,